Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | MIF | P14174 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6793614 | 0.86 | KDM4E (0.31) | MIF | |
| Trifluoroacetic Acid SCHEMBL6789062 | 0.85 | HTR2A (0.35) | HTR2AHTR2CHTR2BMIF | |
| Trifluoroacetic Acid SCHEMBL6787714 | 0.84 | RAD52 (0.31) | — | |
| SCHEMBL6787720 | 0.72 | KDM4E (0.33) | — | |
| Trifluoroacetic Acid SCHEMBL6787410 | 0.72 | CA12 (0.31) | — | |
| SCHEMBL6789065 | 0.71 | MIF (0.34) | MIF | |
| Trifluoroacetic Acid SCHEMBL6786915 | 0.68 | ESR1 (0.33) | — | |
| Trifluoroacetic Acid SCHEMBL6787997 | 0.67 | ESR1 (0.31) | — | |
| SCHEMBL6787413 | 0.66 | — | — | |
| Trifluoroacetic Acid SCHEMBL4715091 | 0.63 | GABRA1 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040127492-A1 | Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 | PHARMACIA CORPORATION | 2004-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127492-A1 | Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 | MKNK2, MAPKAPK2, MAP3K2 | HTR2A 1489/4885HTR2C 1043/4885HTR2B 1812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.